Physician

Joseph Z Ye, MD, PHD

According to 2025 Medicare claims, Joseph Ye, MD, PHD (NPI: 1700881422) practices hematology/oncology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 98506-5028. Ye is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Ye's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 827 traditional Medicare patients, billed 260,140 HCPCS/CPT codes, and received $5,270,820 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,897 prescription claims across 251 beneficiaries totaling $4,461,917 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 12 claims. Open Payments data shows 237 records totaling $1,361,853. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,507,771 to $5,270,820. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $966,418 to $4,461,917. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,319 and ending at $6,696.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	627	250,690	$2,507,771
2016	686	257,704	$2,949,068
2017	681	285,397	$3,511,211
2018	640	270,147	$3,303,526
2019	634	367,242	$4,340,760
2020	881	349,589	$5,653,574
2021	1,031	343,994	$6,361,904
2022	898	391,930	$5,764,215
2023	739	321,187	$5,422,069
2024	827	260,140	$5,270,820

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	237	1,912	$966,418
2016	217	1,843	$1,231,124
2017	223	1,727	$1,833,938
2018	205	1,642	$1,735,075
2019	188	1,491	$2,280,313
2020	245	1,848	$3,266,363
2021	291	2,090	$3,578,720
2022	276	2,111	$4,478,382
2023	280	2,383	$4,599,004
2024	251	1,897	$4,461,917

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	157	$42,287
2016	N/R	80	$29,617
2017	11	86	$5,168
2018	24	170	$13,261
2019	30	187	$14,318
2020	N/R	68	$4,856
2021	13	121	$6,856
2022	N/R	29	$1,513
2023	N/R	N/R	N/R
2024	N/R	12	$603

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	478	1,467	$95
96375	Injection of additional new drug or substance into vein	169	1,000	$12
96372	Injection of drug or substance under skin or into muscle	189	626	$11
36415	Insertion of needle into vein for collection of blood sample	585	1,778	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	551	1,730	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	33	924	$645,637
Lenalidomide	Lenalidomide	38	1,043	$443,303
Ibrance	Palbociclib	27	756	$419,300
Revlimid	Lenalidomide	19	525	$326,593
Ninlaro	Ixazomib Citrate	25	700	$323,463

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	12	$603

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	177	$14,045	Ipsen Biopharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	60	$1,347,808	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph Z. Ye, MD, PHD?

Tedicare shows public-source Medicare data for Joseph Z. Ye, MD, PHD (NPI 1700881422), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Z. Ye, MD, PHD have ACO affiliation data?

Joseph Z. Ye, MD, PHD is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Joseph Z. Ye, MD, PHD?

Joseph Z. Ye, MD, PHD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Joseph Z. Ye, MD, PHD have Open Payments data?

Joseph Z. Ye, MD, PHD has 237 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.